GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quest Laboratories Ltd (NSE:QUESTLAB) » Definitions » Net Income From Continuing Operations

Quest Laboratories (NSE:QUESTLAB) Net Income From Continuing Operations : ₹0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Quest Laboratories Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Quest Laboratories's net income from continuing operations for the three months ended in Mar. 2024 was ₹0.0 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.0 Mil.

Quest Laboratories Net Income From Continuing Operations Historical Data

The historical data trend for Quest Laboratories's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Laboratories Net Income From Continuing Operations Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Net Income From Continuing Operations
7.90 57.67 69.82 144.46

Quest Laboratories Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial - - - - -

Quest Laboratories Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quest Laboratories Ltd (NSE:QUESTLAB) » Definitions » Net Income From Continuing Operations
Comparable Companies
BOM:524774 LLY JNJ ABBV OCSE:NOVO B XSWX:ROG LSE:AZN MRK XSWX:NOVN AMGN PFE GILD XPAR:SAN BMY LSE:GSK TSE:4519 TSE:4568 SHSE:600276 TSE:4578 XTER:BAYN
Traded in Other Exchanges
N/A
Address
Plot No. 45, Sector III, Pithampur Industrial Area, District Dhar, Pithampur, MP, IND, 454775
Website
https://www.questlabltd.com
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids.

Quest Laboratories Headlines

No Headlines